Drug induced vitiligo-like depigmentation from a CDK 4/6 inhibitor

Chan, OB; Su, JC; Yazdabadi, A; Chan, A

Chan, OB (通讯作者),Monash Univ, Dept Dermatol, Eastern Hlth, 5 Arnold St,Box Hill, Melbourne, Vic 3128, Australia.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022; 18 (2): E154

Abstract

Ribociclib is an inhibitor of cyclin-dependent kinases 4 and 6 (CDK 4/6) that is used in combination with an aromatase inhibitor in the first-line set......

Full Text Link